Sintez PJSC, a company of Binnopharm Group, celebrates its 65th anniversary
20.09.2023
In September 2023, Sintez, Kurgan Public Joint-Stock Company of Medicines and Medical Devices, the largest plant of Binnopharm Group, celebrates its 65th anniversary.
Sintez PJSC was established in Kurgan on September 15, 1958. The first product manufactured by the plant was biomycin, antibacterial agent for veterinary use. Today, Sintez PJSC is one of the leading Russian pharmaceutical manufacturers of antibiotics. The plant’s portfolio totals 250 medicinal products, 18 dosage forms. Annually, over 280 million packages of medicines are produced at the plant, half of which are included in the list of vital and essential medicines. Since 2020, Sintez has been part of Binnopharm Group. About two thousand workers are employed at the plant.
Rustem Muratov, Binnopharm Group’s Chief Executive Officer: «First of all, I would like to congratulate our colleagues at Sintez PJSC on this remarkable milestone. Over 65 years, the plant has come a long, and indeed valiant way to become one of the leading pharmaceutical plants to ensure the drug safety of our country. Currently, the drugs manufactured at Sintez are in great demand abroad and are marketed in 13 countries. We are extremely proud to have the plant as part of Binnopharm Group and we will do everything in our power to ensure its future development and success».
Sintez PJSC was established in Kurgan on September 15, 1958. The first product manufactured by the plant was biomycin, antibacterial agent for veterinary use. Today, Sintez PJSC is one of the leading Russian pharmaceutical manufacturers of antibiotics. The plant’s portfolio totals 250 medicinal products, 18 dosage forms. Annually, over 280 million packages of medicines are produced at the plant, half of which are included in the list of vital and essential medicines. Since 2020, Sintez has been part of Binnopharm Group. About two thousand workers are employed at the plant.
Rustem Muratov, Binnopharm Group’s Chief Executive Officer: «First of all, I would like to congratulate our colleagues at Sintez PJSC on this remarkable milestone. Over 65 years, the plant has come a long, and indeed valiant way to become one of the leading pharmaceutical plants to ensure the drug safety of our country. Currently, the drugs manufactured at Sintez are in great demand abroad and are marketed in 13 countries. We are extremely proud to have the plant as part of Binnopharm Group and we will do everything in our power to ensure its future development and success».
